More on NOVN
Data
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $0.09 |
|
|||
| Open | $10.12 | ||||
| 52 Wk High | $23.79 | ||||
| 52 Wk Low | $13.73 | ||||
| Day High | $0.09 | ||||
| Day Low | $0.09 | ||||
| P/E | 0.09 | ||||
| EPS | $1.05 | ||||
| Volume | 1,574,031 | ||||
- Juvenile Idiopathic Arthritis Market is Expected to Expand at a Healthy Growth Rate of 5.6% During the Forecast Period (2026-2036) | DelveInsight
- Form 144 NOVARTIS AG Filed by: Marshall Fiona
- Form 144 NOVARTIS AG Filed by: Bulto Carulla Victor
- Form S-8 NOVARTIS AG
- Form 6-K NOVARTIS AG For: Dec 31
- Form 6-K NOVARTIS AG For: Dec 31
- Form IRANNOTICE NOVARTIS AG
- Form 20-F NOVARTIS AG For: Dec 31
- NFL Greats and Novartis Tackle Prostate Cancer Myths at Super Bowl LX: "Relax, It's a Blood Test"
- Citi initiates coverage of European pharma stocks; AstraZeneca 'best in class'
Entities mentioned with NOVN
- FDA | View Related Stories »
- Twitter | View Related Stories »
- Definitive Agreement | View Related Stories »
- Earnings | View Related Stories »
- Donald J. Trump | View Related Stories »
- H.C. Wainwright | View Related Stories »
- PDUFA | View Related Stories »
- JPMorgan | View Related Stories »
- Show More...
